|
|
| |||||||||||||||||||||||||||||||||||||||||||||||
Background Emergency postcoital contraception prevents pregnancy, but it must be prescribed by a doctor and taken within 72 hours of intercourse. It has been proposed that emergency contraception be made available without a prescription. We undertook a study to learn how women might behave if given a supply of emergency contraceptive pills to keep at home.
Methods We assigned 553 women to be given a replaceable supply of hormonal emergency contraceptive pills to take home (the treatment group) and 530 women to use emergency contraception obtained by visiting a doctor (the control group). The frequency of use of emergency contraception, the use of other contraceptives, and the incidence of unwanted pregnancy were determined in both groups of women one year later.
Results The results for 549 women in the treatment group and 522 women in the control group were available for analysis. Three hundred seventy-nine of the women in the treatment group (69 percent) and 326 of the women in the control group (62 percent) contributed detailed information at follow-up. One hundred eighty of the women in the treatment group (47 percent) used emergency contraception at least once. Among those who returned the study questionnaire, 98 percent used emergency contraception correctly. There were no serious adverse effects. Eighty-seven women in the control group (27 percent) used emergency contraception at least once (P<0.001 for the comparison with the treatment group). The women in the treatment group were not more likely to use emergency contraception repeatedly. Their use of other methods of contraception was no different from that of the women in the control group. There were 18 unintended pregnancies in the treatment group and 25 in the control group (relative risk, 0.7; 95 percent confidence interval, 0.4 to 1.2).
Conclusions Making emergency contraception more easily obtainable does no harm and may reduce the rate of unwanted pregnancies.
Although in some countries health ministers have considered making emergency contraception available without a prescription and selling it in pharmacies,4,5 for several reasons this has not yet happened. Pharmaceutical companies worry about litigation. Pharmacists are concerned about requests from girls under 16 years of age (the legal age of consent to sexual relations in the United Kingdom). Many doctors and the public believe that easy access to emergency contraception would encourage promiscuity and unsafe sexual relations and discourage the use of more reliable contraception.
However, the benefits of making hormonal emergency contraception available without a prescription may outweigh the difficulties. With this in mind, we investigated how women might behave if emergency contraception were more readily available and the effect that such availability might have on the number of unintended pregnancies.
Methods
We studied 1083 women, 16 to 44 years old, who were attending a family-planning clinic and a large hospital in Edinburgh, Scotland, from January 1994 through December 1996. Six hundred fifty women were recruited at their follow-up consultations after using emergency contraception, and 433 after therapeutic abortion. Women in whom estrogen was contraindicated (those with a history of arterial disease, venous thromboembolism, or severe migraine) were excluded.
After a routine consultation during which future contraception was discussed and contraceptive agents provided, the women who agreed to participate in the study were assigned to the treatment or control group on the basis of their dates of birth (women whose birthdays fell on even-numbered days were assigned to the treatment group). The women in the treatment group were given one packet of emergency hormonal contraceptive tablets to keep at home (four tablets, each containing 50 µg of ethinyl estradiol and 0.25 mg of levonorgestrel [Schering PC4, Schering Health Care, Burgess Hill, West Sussex, United Kingdom]), with instructions to take two tablets within 72 hours after intercourse and two tablets 12 hours later. They were also given written instructions and a telephone number to call in case they had questions. If emergency contraception was used, the women were instructed to mail a notification form to the clinic, with the time of intercourse, the time the pills were taken, and the date of the last menstrual period recorded. They also were instructed to come to the clinic within one week after the date of the expected next menstrual period, at which time the details of the emergency contraceptive use were verified and a pregnancy test was performed if indicated. If the woman was not pregnant, future contraception was discussed; if she wished to continue taking part in the study, she was given a replacement packet of emergency contraceptive pills and notification forms.
The women in the control group were simply informed of or reminded about how to use emergency contraception and where to get it and that it was safe to use it more than once. They were given a notification form to mail in if they used emergency contraception at any time during the next year.
All the women in both groups were sent a questionnaire after one year asking about the details of their use of contraception (including emergency contraception), about any pregnancies, whether they thought emergency contraception should be available without prescription, and how much they would be willing to pay for it. If the questionnaire was not returned, two additional questionnaires were sent. If we did not receive a response, we contacted the woman's family doctor to obtain information about her use of contraception and whether she had become pregnant. If the family doctor could not provide the information, the woman was deemed lost to follow-up and the information was sought from the Information and Statistics Division of the Scottish Health Department (to which all births and therapeutic abortions are reported) to determine whether she had been pregnant during the year.
The study was approved by the Lothian Research Ethics Committee with the stipulation that women using emergency contraception more than four times in four months be withdrawn from the study. All the women gave informed consent.
Statistical Analysis
Differences between the groups were tested by chi-square tests with Yates' correction for binary factors or Mann–Whitney tests for ordinal factors.
Results
The results for 1071 women (549 in the treatment group and 522 in the control group) were available for analysis. One woman was withdrawn from the study because she used emergency contraception more than four times in four months. One woman in the control group died in a traffic accident, and 10 women (3 in the treatment group and 7 in the control group) dropped out of the study for personal reasons. None of these women had used emergency contraception before they left the study.
The characteristics of the women in the two groups were similar (Table 1). The women in the treatment group were more likely to return their final questionnaires (P=0.03). The women returning the final questionnaire were older (P<0.001) and more likely to have been recruited after use of emergency contraception than after an abortion (P<0.01). There was no effect of education on whether the women returned the questionnaires (P=0.52).
|
|
The condom was the most common method of contraception at the start of the study (Table 3). During the subsequent year, many women in each group abandoned condoms in favor of hormonal contraception, but there was no significant difference between the groups (P=0.07). Eighty-nine percent of the women in the treatment group said that their use of other methods of contraception was unaffected, and 8 percent reported that the availability of emergency contraception gave them "peace of mind," but 2 percent said that they took more risks.
|
|
Discussion
The results of this study suggest that making emergency contraception available at home is safe and may reduce the risk of unintended pregnancy. However, it is important to note that we studied a well-defined group of women who we thought were likely to use emergency contraception because they had used it previously or because they had terminated a pregnancy. Furthermore, the women were well educated (less than 20 percent had left school before the age of 16 years, and half had gone to a university or college) and were likely to have a responsible attitude toward contraception. Nevertheless, we think the study suggests what might happen if emergency contraception were made available without a prescription.
Emergency contraception is not universally available. It is not licensed, for example, in France or the United States. However, some brands of combined oral contraceptives contain the same hormones as the preparation we used, and although not licensed for such use, these contraceptives can be used as a substitute. Many clinics in the United Kingdom routinely use these oral contraceptives for emergency contraception because they are considerably cheaper than the marketed preparation we used, and many women have supplies of oral-contraceptive pills at home and could make up their own emergency contraceptive regimen if they knew how. Indeed, in 1997 the U.S. Food and Drug Administration announced that six brands of commonly used combined oral contraceptive pills are safe and effective for use as emergency postcoital contraceptives.7
It has been argued that if emergency contraception were available without a prescription, women would not use it correctly. We found, however, that most of the women did use it correctly, including many who were recruited after abortions and had never used such contraception before. It is also possible that women might use emergency contraception when they are already pregnant. We cannot test this hypothesis. A small number of women in our study conceived during the cycle in which they used emergency contraception, and it is possible that some of them were already pregnant when they took the tablets. Even if it was used during pregnancy, either in error or intentionally in the mistaken belief that it might cause an abortion, it would almost certainly have done no harm. The estrogen–progestin regimen of emergency contraception is ineffective after implantation, and there is no evidence that it is teratogenic.8
It has also been argued that if emergency contraception were more readily accessible, women might use it repeatedly and abandon more reliable methods of contraception. However, very few of the women in the treatment group used it more than once, and they were not more likely to do so than the women in the control group who had to visit a doctor to obtain it. Nor did improved accessibility affect the pattern of contraceptive use. Few women said that they took more risks, and during the study similar numbers in each group switched from using barrier methods to using more reliable oral contraception.
Although the incidence of unintended pregnancy was lower among the women who had emergency contraception available at home than among those who had to obtain it from a doctor, the sample was small and the difference was not statistically significant. The reduction in the number of unintended pregnancies might have been greater if we had given more than one packet of pills to each woman. Although 135 women used emergency contraception once, only 74 returned to the clinic for another packet.
This study suggests that women are able to self-administer emergency contraception correctly, at the appropriate time, and without adverse effects. Given the opportunity to keep the necessary tablets at home, most of the women found emergency contraception a useful addition to their contraceptive options. Although many of the women thought that it should be available without a prescription, they did not appear to abandon more reliable methods of contraception in favor of the repeated use of emergency contraception. Making emergency contraception more accessible may reduce the rate of unintended pregnancies.
Supported by a grant from the Chief Scientist's Office of the Scottish Home and Health Department.
We are indebted to Ann Mayo and Janet Logan for assistance with data collection; to Dr. Marion Bain of the Information and Statistics Division of the Scottish Health Service for information on women lost to follow-up; to Dr. Rob Elton for help with statistical analysis; and to the staff and patients of the Dean Terrace Centre and Edinburgh Royal Infirmary for their part in the study.
Source Information
From the Edinburgh Healthcare National Health Service Trust Family Planning and Well Woman Services (A.G.) and the Department of Obstetrics and Gynaecology, University of Edinburgh (A.G., D.B.) — both in Edinburgh, Scotland.
Address reprint requests to Dr. Glasier at the Department of Obstetrics and Gynaecology, University of Edinburgh, 18 Dean Terr., Edinburgh EH4 1NL, Scotland, United Kingdom.
References
| |||||||||||||||||||||||||||||||||||||||||||||||
Related Letters:
The Effects of Self-Administering Emergency Contraception
Gardner J. S., Fuller T. S., Hutchings J.
Extract |
Full Text
N Engl J Med 1998;
339:1395, Nov 5, 1998.
Correspondence
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |
